GetTopicDetailResponse(id=e0e91535453, topicName=RESOLVE, introduction=RESOLVE, content=null, image=null, comments=5, allHits=904, url=https://h5.medsci.cn/topic?id=15354, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=17834, tagList=[TagDto(tagId=17834, tagName=RESOLVE)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1793272, encodeId=b6091e93272cd, content=<a href='/topic/show?id=e0e91535453' target=_blank style='color:#2F92EE;'>#RESOLVE#</a>, objectTitle=LANCET ONCOL：圍手術(shù)期或術(shù)后輔助奧沙利鉑聯(lián)合S-1 vs術(shù)后輔助奧沙利鉑聯(lián)合卡培他濱在接受D2胃切除術(shù)的局部進(jìn)展期胃或胃食管結(jié)合部腺癌患者的療效和安全性(RESOLVE): 一項(xiàng)開(kāi)放標(biāo)簽、優(yōu)效性和非劣效的3期隨機(jī)對(duì)照研究, objectType=article, longId=214070, objectId=468d2140e0fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468d2140e0fd, replyNumber=0, likeNumber=97, createdTime=2021-10-09, rootId=0, userName=ms49895894946433513521, userId=9e302500146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468d2140e0fd, moduleTitle=LANCET ONCOL：圍手術(shù)期或術(shù)后輔助奧沙利鉑聯(lián)合S-1 vs術(shù)后輔助奧沙利鉑聯(lián)合卡培他濱在接受D2胃切除術(shù)的局部進(jìn)展期胃或胃食管結(jié)合部腺癌患者的療效和安全性(RESOLVE): 一項(xiàng)開(kāi)放標(biāo)簽、優(yōu)效性和非劣效的3期隨機(jī)對(duì)照研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=468d2140e0fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793273, encodeId=44a21e9327330, content=<a href='/topic/show?id=e0e91535453' target=_blank style='color:#2F92EE;'>#RESOLVE#</a>, objectTitle=J Urol：Cxbladder Resolve（CxbR）在尿路上皮癌風(fēng)險(xiǎn)患者中的診斷性能如何？, objectType=article, longId=216547, objectId=3cdd21654ee5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cdd21654ee5, replyNumber=0, likeNumber=108, createdTime=2021-11-11, rootId=0, userName=ms49895894946433513521, userId=9e302500146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cdd21654ee5, moduleTitle=J Urol：Cxbladder Resolve（CxbR）在尿路上皮癌風(fēng)險(xiǎn)患者中的診斷性能如何？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3cdd21654ee5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793271, encodeId=4ab21e93271ad, content=<a href='/topic/show?id=e0e91535453' target=_blank style='color:#2F92EE;'>#RESOLVE#</a>, objectTitle=JCEM：生活方式干預(yù)對(duì)代謝綜合征患者血管胰島素抵抗的影響（Resolve研究）, objectType=article, longId=41990, objectId=4bb841990b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb841990b4, replyNumber=0, likeNumber=87, createdTime=2015-08-25, rootId=0, userName=ms49895894946433513521, userId=9e302500146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb841990b4, moduleTitle=JCEM：生活方式干預(yù)對(duì)代謝綜合征患者血管胰島素抵抗的影響（Resolve研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4bb841990b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793269, encodeId=ccc31e932695e, content=<a href='/topic/show?id=e0e91535453' target=_blank style='color:#2F92EE;'>#RESOLVE#</a>, objectTitle=CIT 2014：冠脈分叉病變RESOLVE評(píng)分, objectType=article, longId=31827, objectId=657b3182e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=657b3182e08, replyNumber=0, likeNumber=105, createdTime=2015-01-30, rootId=0, userName=ms49895894946433513521, userId=9e302500146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=657b3182e08, moduleTitle=CIT 2014：冠脈分叉病變RESOLVE評(píng)分, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=657b3182e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793270, encodeId=a51a1e932709b, content=<a href='/topic/show?id=e0e91535453' target=_blank style='color:#2F92EE;'>#RESOLVE#</a>, objectTitle=CIT 2014：冠脈分叉病變RESOLVE評(píng)分, objectType=article, longId=32134, objectId=385d32134ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=385d32134ac, replyNumber=0, likeNumber=137, createdTime=2014-07-10, rootId=0, userName=ms49895894946433513521, userId=9e302500146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=385d32134ac, moduleTitle=CIT 2014：冠脈分叉病變RESOLVE評(píng)分, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=385d32134ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
